APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle Solutions

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lipid Nanoparticle Solutions Market Analysis and Forecast 2026-2032

Report ID 174177360216 April 2026188 pages

Choose your research edition.

Industry ResearchLipid Nanoparticle Solutions Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle Solutions Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle Solutions Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle Solutions Market Analysis and Forecast 2026-2032188 pages · $4,950 USD

Market perspective

The global Lipid Nanoparticle Solutions market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Lipid Nanoparticle Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lipid Nanoparticle Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lipid Nanoparticle Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lipid Nanoparticle Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Lipid Nanoparticle Solutions include Merck, Cytiva, GenScript, Creative Biolabs, WuXi STA, Carcell, Croda International, Detai Biotechnology and Waters, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Lipid Nanoparticle Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lipid Nanoparticle Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for Lipid Nanoparticle Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lipid Nanoparticle Solutions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lipid Nanoparticle Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Lipid Nanoparticle Solutions revenue, projected growth trends, production technology, application and end-user industry.

Lipid Nanoparticle Solutions Segment by Company

Merck

Cytiva

GenScript

Creative Biolabs

WuXi STA

Carcell

Croda International

Detai Biotechnology

Waters

MicroNano Biologics

Precigenome

Evonik

Avanti Polar Lipids

Genevant Sciences

Exelead

Nippon Fine Chemical

Lipoid

Lipid Nanoparticle Solutions Segment by Type

Solid Lipid Nanoparticles

Nanostructured Lipid Carriers

Cationic Lipid-Nucleic Acid Complexes

Lipid Nanoparticle Solutions Segment by Application

Gene Therapy

Vaccine Development

Cancer Treatment

Lipid Nanoparticle Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Lipid Nanoparticle Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Lipid Nanoparticle Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Nanoparticle Solutions revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lipid Nanoparticle Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Solid Lipid Nanoparticles Major Player Table 3. Nanostructured Lipid Carriers Major Player Table 4. Cationic Lipid-Nucleic Acid Complexes Major Player Table 5. Global Lipid Nanoparticle Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Gene Therapy Major Player Table 7. Vaccine Development Major Player Table 8. Cancer Treatment Major Player Table 9. Lipid Nanoparticle Solutions Industry Trends Table 10. Lipid Nanoparticle Solutions Industry Drivers Table 11. Lipid Nanoparticle Solutions Industry Opportunities and Challenges Table 12. Lipid Nanoparticle Solutions Industry Restraints Table 13. Global Lipid Nanoparticle Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Lipid Nanoparticle Solutions Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Lipid Nanoparticle Solutions Market Share by Region (2021-2026) Table 16. Global Lipid Nanoparticle Solutions Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Lipid Nanoparticle Solutions Market Share by Region (2027-2032) Table 18. Global Lipid Nanoparticle Solutions Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Lipid Nanoparticle Solutions Revenue Market Share by Players (2021-2026) Table 20. Global Lipid Nanoparticle Solutions Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Lipid Nanoparticle Solutions Key Players Headquarters & Area Served Table 22. Global Lipid Nanoparticle Solutions Players, Product Type & Application Table 23. Global Lipid Nanoparticle Solutions Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Lipid Nanoparticle Solutions by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Lipid Nanoparticle Solutions Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Lipid Nanoparticle Solutions Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Lipid Nanoparticle Solutions Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Lipid Nanoparticle Solutions Revenue Market Share by Type (2021-2026) Table 30. Global Lipid Nanoparticle Solutions Revenue Market Share by Type (2027-2032) Table 31. Global Lipid Nanoparticle Solutions Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Lipid Nanoparticle Solutions Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Lipid Nanoparticle Solutions Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Lipid Nanoparticle Solutions Revenue Market Share by Application (2021-2026) Table 35. Global Lipid Nanoparticle Solutions Revenue Market Share by Application (2027-2032) Table 36. Merck Company Information Table 37. Merck Business Overview Table 38. Merck Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Merck Lipid Nanoparticle Solutions Product Portfolio Table 40. Merck Recent Development Table 41. Cytiva Company Information Table 42. Cytiva Business Overview Table 43. Cytiva Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Cytiva Lipid Nanoparticle Solutions Product Portfolio Table 45. Cytiva Recent Development Table 46. GenScript Company Information Table 47. GenScript Business Overview Table 48. GenScript Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. GenScript Lipid Nanoparticle Solutions Product Portfolio Table 50. GenScript Recent Development Table 51. Creative Biolabs Company Information Table 52. Creative Biolabs Business Overview Table 53. Creative Biolabs Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Creative Biolabs Lipid Nanoparticle Solutions Product Portfolio Table 55. Creative Biolabs Recent Development Table 56. WuXi STA Company Information Table 57. WuXi STA Business Overview Table 58. WuXi STA Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. WuXi STA Lipid Nanoparticle Solutions Product Portfolio Table 60. WuXi STA Recent Development Table 61. Carcell Company Information Table 62. Carcell Business Overview Table 63. Carcell Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Carcell Lipid Nanoparticle Solutions Product Portfolio Table 65. Carcell Recent Development Table 66. Croda International Company Information Table 67. Croda International Business Overview Table 68. Croda International Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Croda International Lipid Nanoparticle Solutions Product Portfolio Table 70. Croda International Recent Development Table 71. Detai Biotechnology Company Information Table 72. Detai Biotechnology Business Overview Table 73. Detai Biotechnology Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Detai Biotechnology Lipid Nanoparticle Solutions Product Portfolio Table 75. Detai Biotechnology Recent Development Table 76. Waters Company Information Table 77. Waters Business Overview Table 78. Waters Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Waters Lipid Nanoparticle Solutions Product Portfolio Table 80. Waters Recent Development Table 81. MicroNano Biologics Company Information Table 82. MicroNano Biologics Business Overview Table 83. MicroNano Biologics Lipid Nanoparticle Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. MicroNano Biologics Lipid Nanoparticle Solutions Product Portfolio Table 85. MicroNano Biologics Recent Development Table 86. Precigenome Company Information Table 87. Precigenome Business Overview Table 88. Precigenome Lipid Nanoparticle Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Precigenome Lipid Nanoparticle Solutions Product Portfolio Table 90. Precigenome Recent Development Table 91. Evonik Company Information Table 92. Evonik Business Overview Table 93. Evonik Lipid Nanoparticle Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Evonik Lipid Nanoparticle Solutions Product Portfolio Table 95. Evonik Recent Development Table 96. Avanti Polar Lipids Company Information Table 97. Avanti Polar Lipids Business Overview Table 98. Avanti Polar Lipids Lipid Nanoparticle Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Avanti Polar Lipids Lipid Nanoparticle Solutions Product Portfolio Table 100. Avanti Polar Lipids Recent Development Table 101. Genevant Sciences Company Information Table 102. Genevant Sciences Business Overview Table 103. Genevant Sciences Lipid Nanoparticle Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Genevant Sciences Lipid Nanoparticle Solutions Product Portfolio Table 105. Genevant Sciences Recent Development Table 106. Exelead Company Information Table 107. Exelead Business Overview Table 108. Exelead Lipid Nanoparticle Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Exelead Lipid Nanoparticle Solutions Product Portfolio Table 110. Exelead Recent Development Table 111. Nippon Fine Chemical Company Information Table 112. Nippon Fine Chemical Business Overview Table 113. Nippon Fine Chemical Lipid Nanoparticle Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Nippon Fine Chemical Lipid Nanoparticle Solutions Product Portfolio Table 115. Nippon Fine Chemical Recent Development Table 116. Lipoid Company Information Table 117. Lipoid Business Overview Table 118. Lipoid Lipid Nanoparticle Solutions Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Lipoid Lipid Nanoparticle Solutions Product Portfolio Table 120. Lipoid Recent Development Table 121. North America Lipid Nanoparticle Solutions Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Lipid Nanoparticle Solutions Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Lipid Nanoparticle Solutions Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Lipid Nanoparticle Solutions Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Lipid Nanoparticle Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Lipid Nanoparticle Solutions Revenue by Country (2021-2026) & (US$ Million) Table 127. North America Lipid Nanoparticle Solutions Revenue by Country (US$ Million) & (2027-2032) Table 128. Europe Lipid Nanoparticle Solutions Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Lipid Nanoparticle Solutions Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Lipid Nanoparticle Solutions Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Lipid Nanoparticle Solutions Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Lipid Nanoparticle Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Lipid Nanoparticle Solutions Revenue by Country (2021-2026) & (US$ Million) Table 134. Europe Lipid Nanoparticle Solutions Revenue by Country (US$ Million) & (2027-2032) Table 135. China Lipid Nanoparticle Solutions Revenue by Type (2021-2026) & (US$ Million) Table 136. China Lipid Nanoparticle Solutions Revenue by Type (2027-2032) & (US$ Million) Table 137. China Lipid Nanoparticle Solutions Revenue by Application (2021-2026) & (US$ Million) Table 138. China Lipid Nanoparticle Solutions Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Lipid Nanoparticle Solutions Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Lipid Nanoparticle Solutions Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Lipid Nanoparticle Solutions Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Lipid Nanoparticle Solutions Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Lipid Nanoparticle Solutions Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Lipid Nanoparticle Solutions Revenue by Region (US$ Million) & (2021-2026) Table 145. Asia Lipid Nanoparticle Solutions Revenue by Region (US$ Million) & (2027-2032) Table 146. SAMEA Lipid Nanoparticle Solutions Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA Lipid Nanoparticle Solutions Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA Lipid Nanoparticle Solutions Revenue by Application (2021-2026) & (US$ Million) Table 149. SAMEA Lipid Nanoparticle Solutions Revenue by Application (2027-2032) & (US$ Million) Table 150. SAMEA Lipid Nanoparticle Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. SAMEA Lipid Nanoparticle Solutions Revenue by Country (2021-2026) & (US$ Million) Table 152. SAMEA Lipid Nanoparticle Solutions Revenue by Country (US$ Million) & (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Lipid Nanoparticle Solutions Image Figure 2. Global Lipid Nanoparticle Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lipid Nanoparticle Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 4. Solid Lipid Nanoparticles Image Figure 5. Nanostructured Lipid Carriers Image Figure 6. Cationic Lipid-Nucleic Acid Complexes Image Figure 7. Global Lipid Nanoparticle Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Lipid Nanoparticle Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 9. Gene Therapy Image Figure 10. Vaccine Development Image Figure 11. Cancer Treatment Image Figure 12. Global Lipid Nanoparticle Solutions Market Size (US$ Million) & (2021-2032) Figure 13. Global Lipid Nanoparticle Solutions Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Lipid Nanoparticle Solutions Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Lipid Nanoparticle Solutions Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Lipid Nanoparticle Solutions Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Lipid Nanoparticle Solutions Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Lipid Nanoparticle Solutions Revenue Market Share by Type (2021-2032) Figure 20. Global Lipid Nanoparticle Solutions Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Lipid Nanoparticle Solutions Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Lipid Nanoparticle Solutions Revenue Market Share by Application (2021-2032) Figure 23. North America Lipid Nanoparticle Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032) Figure 25. North America Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032) Figure 26. North America Lipid Nanoparticle Solutions Revenue Share by Country (2021-2032) Figure 27. United States Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Lipid Nanoparticle Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032) Figure 32. Europe Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032) Figure 33. Europe Lipid Nanoparticle Solutions Revenue Share by Country (2021-2032) Figure 34. Germany Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Lipid Nanoparticle Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032) Figure 44. China Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032) Figure 45. Asia Lipid Nanoparticle Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032) Figure 47. Asia Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032) Figure 48. Asia Lipid Nanoparticle Solutions Revenue Share by Region (2021-2032) Figure 49. Japan Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Lipid Nanoparticle Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032) Figure 57. SAMEA Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032) Figure 58. SAMEA Lipid Nanoparticle Solutions Revenue Share by Country (2021-2032) Figure 59. Brazil Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Lipid Nanoparticle Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
  • Cationic Lipid-Nucleic Acid Complexes
Applications
  • Gene Therapy
  • Vaccine Development
  • Cancer Treatment
Companies covered
  • Merck
  • Cytiva
  • GenScript
  • Creative Biolabs
  • WuXi STA
  • Carcell
  • Croda International
  • Detai Biotechnology
  • Waters
  • MicroNano Biologics
  • Precigenome
  • Evonik
  • Avanti Polar Lipids
  • Genevant Sciences
  • Exelead
  • Nippon Fine Chemical
  • Lipoid

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lipid Nanoparticle Solutions Market by Type
  3. 1.2.1 Global Lipid Nanoparticle Solutions Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Solid Lipid Nanoparticles
  5. 1.2.3 Nanostructured Lipid Carriers
  6. 1.2.4 Cationic Lipid-Nucleic Acid Complexes
  7. 1.3 Lipid Nanoparticle Solutions Market by Application
  8. 1.3.1 Global Lipid Nanoparticle Solutions Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Gene Therapy
  10. 1.3.3 Vaccine Development
  11. 1.3.4 Cancer Treatment
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Lipid Nanoparticle Solutions Market Dynamics
  1. 2.1 Lipid Nanoparticle Solutions Industry Trends
  2. 2.2 Lipid Nanoparticle Solutions Industry Drivers
  3. 2.3 Lipid Nanoparticle Solutions Industry Opportunities and Challenges
  4. 2.4 Lipid Nanoparticle Solutions Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Lipid Nanoparticle Solutions Market Perspective (2021-2032)
  2. 3.2 Global Lipid Nanoparticle Solutions Growth Trends by Region
  3. 3.2.1 Global Lipid Nanoparticle Solutions Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lipid Nanoparticle Solutions Market Size by Region (2021-2026)
  5. 3.2.3 Global Lipid Nanoparticle Solutions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Lipid Nanoparticle Solutions Revenue by Players
  2. 4.1.1 Global Lipid Nanoparticle Solutions Revenue by Players (2021-2026)
  3. 4.1.2 Global Lipid Nanoparticle Solutions Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Lipid Nanoparticle Solutions Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lipid Nanoparticle Solutions Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Lipid Nanoparticle Solutions Key Players Headquarters & Area Served
  7. 4.4 Global Lipid Nanoparticle Solutions Players, Product Type & Application
  8. 4.5 Global Lipid Nanoparticle Solutions Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Lipid Nanoparticle Solutions Market CR5 and HHI
  11. 4.6.3 2025 Lipid Nanoparticle Solutions Tier 1, Tier 2, and Tier 3
5 Lipid Nanoparticle Solutions Market Size by Type
  1. 5.1 Global Lipid Nanoparticle Solutions Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Lipid Nanoparticle Solutions Revenue by Type (2021-2032)
  3. 5.3 Global Lipid Nanoparticle Solutions Revenue Market Share by Type (2021-2032)
6 Lipid Nanoparticle Solutions Market Size by Application
  1. 6.1 Global Lipid Nanoparticle Solutions Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Lipid Nanoparticle Solutions Revenue by Application (2021-2032)
  3. 6.3 Global Lipid Nanoparticle Solutions Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck Lipid Nanoparticle Solutions Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Cytiva
  8. 7.2.1 Cytiva Company Information
  9. 7.2.2 Cytiva Business Overview
  10. 7.2.3 Cytiva Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cytiva Lipid Nanoparticle Solutions Product Portfolio
  12. 7.2.5 Cytiva Recent Developments
  13. 7.3 GenScript
  14. 7.3.1 GenScript Company Information
  15. 7.3.2 GenScript Business Overview
  16. 7.3.3 GenScript Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GenScript Lipid Nanoparticle Solutions Product Portfolio
  18. 7.3.5 GenScript Recent Developments
  19. 7.4 Creative Biolabs
  20. 7.4.1 Creative Biolabs Company Information
  21. 7.4.2 Creative Biolabs Business Overview
  22. 7.4.3 Creative Biolabs Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Creative Biolabs Lipid Nanoparticle Solutions Product Portfolio
  24. 7.4.5 Creative Biolabs Recent Developments
  25. 7.5 WuXi STA
  26. 7.5.1 WuXi STA Company Information
  27. 7.5.2 WuXi STA Business Overview
  28. 7.5.3 WuXi STA Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  29. 7.5.4 WuXi STA Lipid Nanoparticle Solutions Product Portfolio
  30. 7.5.5 WuXi STA Recent Developments
  31. 7.6 Carcell
  32. 7.6.1 Carcell Company Information
  33. 7.6.2 Carcell Business Overview
  34. 7.6.3 Carcell Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Carcell Lipid Nanoparticle Solutions Product Portfolio
  36. 7.6.5 Carcell Recent Developments
  37. 7.7 Croda International
  38. 7.7.1 Croda International Company Information
  39. 7.7.2 Croda International Business Overview
  40. 7.7.3 Croda International Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Croda International Lipid Nanoparticle Solutions Product Portfolio
  42. 7.7.5 Croda International Recent Developments
  43. 7.8 Detai Biotechnology
  44. 7.8.1 Detai Biotechnology Company Information
  45. 7.8.2 Detai Biotechnology Business Overview
  46. 7.8.3 Detai Biotechnology Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Detai Biotechnology Lipid Nanoparticle Solutions Product Portfolio
  48. 7.8.5 Detai Biotechnology Recent Developments
  49. 7.9 Waters
  50. 7.9.1 Waters Company Information
  51. 7.9.2 Waters Business Overview
  52. 7.9.3 Waters Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Waters Lipid Nanoparticle Solutions Product Portfolio
  54. 7.9.5 Waters Recent Developments
  55. 7.10 MicroNano Biologics
  56. 7.10.1 MicroNano Biologics Company Information
  57. 7.10.2 MicroNano Biologics Business Overview
  58. 7.10.3 MicroNano Biologics Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  59. 7.10.4 MicroNano Biologics Lipid Nanoparticle Solutions Product Portfolio
  60. 7.10.5 MicroNano Biologics Recent Developments
  61. 7.11 Precigenome
  62. 7.11.1 Precigenome Company Information
  63. 7.11.2 Precigenome Business Overview
  64. 7.11.3 Precigenome Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Precigenome Lipid Nanoparticle Solutions Product Portfolio
  66. 7.11.5 Precigenome Recent Developments
  67. 7.12 Evonik
  68. 7.12.1 Evonik Company Information
  69. 7.12.2 Evonik Business Overview
  70. 7.12.3 Evonik Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Evonik Lipid Nanoparticle Solutions Product Portfolio
  72. 7.12.5 Evonik Recent Developments
  73. 7.13 Avanti Polar Lipids
  74. 7.13.1 Avanti Polar Lipids Company Information
  75. 7.13.2 Avanti Polar Lipids Business Overview
  76. 7.13.3 Avanti Polar Lipids Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Avanti Polar Lipids Lipid Nanoparticle Solutions Product Portfolio
  78. 7.13.5 Avanti Polar Lipids Recent Developments
  79. 7.14 Genevant Sciences
  80. 7.14.1 Genevant Sciences Company Information
  81. 7.14.2 Genevant Sciences Business Overview
  82. 7.14.3 Genevant Sciences Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Genevant Sciences Lipid Nanoparticle Solutions Product Portfolio
  84. 7.14.5 Genevant Sciences Recent Developments
  85. 7.15 Exelead
  86. 7.15.1 Exelead Company Information
  87. 7.15.2 Exelead Business Overview
  88. 7.15.3 Exelead Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Exelead Lipid Nanoparticle Solutions Product Portfolio
  90. 7.15.5 Exelead Recent Developments
  91. 7.16 Nippon Fine Chemical
  92. 7.16.1 Nippon Fine Chemical Company Information
  93. 7.16.2 Nippon Fine Chemical Business Overview
  94. 7.16.3 Nippon Fine Chemical Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Nippon Fine Chemical Lipid Nanoparticle Solutions Product Portfolio
  96. 7.16.5 Nippon Fine Chemical Recent Developments
  97. 7.17 Lipoid
  98. 7.17.1 Lipoid Company Information
  99. 7.17.2 Lipoid Business Overview
  100. 7.17.3 Lipoid Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Lipoid Lipid Nanoparticle Solutions Product Portfolio
  102. 7.17.5 Lipoid Recent Developments
8 North America
  1. 8.1 North America Lipid Nanoparticle Solutions Revenue (2021-2032)
  2. 8.2 North America Lipid Nanoparticle Solutions Revenue by Type (2021-2032)
  3. 8.2.1 North America Lipid Nanoparticle Solutions Revenue by Type (2021-2026)
  4. 8.2.2 North America Lipid Nanoparticle Solutions Revenue by Type (2027-2032)
  5. 8.3 North America Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032)
  6. 8.4 North America Lipid Nanoparticle Solutions Revenue by Application (2021-2032)
  7. 8.4.1 North America Lipid Nanoparticle Solutions Revenue by Application (2021-2026)
  8. 8.4.2 North America Lipid Nanoparticle Solutions Revenue by Application (2027-2032)
  9. 8.5 North America Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032)
  10. 8.6 North America Lipid Nanoparticle Solutions Revenue by Country
  11. 8.6.1 North America Lipid Nanoparticle Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Lipid Nanoparticle Solutions Revenue by Country (2021-2026)
  13. 8.6.3 North America Lipid Nanoparticle Solutions Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Lipid Nanoparticle Solutions Revenue (2021-2032)
  2. 9.2 Europe Lipid Nanoparticle Solutions Revenue by Type (2021-2032)
  3. 9.2.1 Europe Lipid Nanoparticle Solutions Revenue by Type (2021-2026)
  4. 9.2.2 Europe Lipid Nanoparticle Solutions Revenue by Type (2027-2032)
  5. 9.3 Europe Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032)
  6. 9.4 Europe Lipid Nanoparticle Solutions Revenue by Application (2021-2032)
  7. 9.4.1 Europe Lipid Nanoparticle Solutions Revenue by Application (2021-2026)
  8. 9.4.2 Europe Lipid Nanoparticle Solutions Revenue by Application (2027-2032)
  9. 9.5 Europe Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032)
  10. 9.6 Europe Lipid Nanoparticle Solutions Revenue by Country
  11. 9.6.1 Europe Lipid Nanoparticle Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Lipid Nanoparticle Solutions Revenue by Country (2021-2026)
  13. 9.6.3 Europe Lipid Nanoparticle Solutions Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Lipid Nanoparticle Solutions Revenue (2021-2032)
  2. 10.2 China Lipid Nanoparticle Solutions Revenue by Type (2021-2032)
  3. 10.2.1 China Lipid Nanoparticle Solutions Revenue by Type (2021-2026)
  4. 10.2.2 China Lipid Nanoparticle Solutions Revenue by Type (2027-2032)
  5. 10.3 China Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032)
  6. 10.4 China Lipid Nanoparticle Solutions Revenue by Application (2021-2032)
  7. 10.4.1 China Lipid Nanoparticle Solutions Revenue by Application (2021-2026)
  8. 10.4.2 China Lipid Nanoparticle Solutions Revenue by Application (2027-2032)
  9. 10.5 China Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lipid Nanoparticle Solutions Revenue (2021-2032)
  2. 11.2 Asia Lipid Nanoparticle Solutions Revenue by Type (2021-2032)
  3. 11.2.1 Asia Lipid Nanoparticle Solutions Revenue by Type (2021-2026)
  4. 11.2.2 Asia Lipid Nanoparticle Solutions Revenue by Type (2027-2032)
  5. 11.3 Asia Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032)
  6. 11.4 Asia Lipid Nanoparticle Solutions Revenue by Application (2021-2032)
  7. 11.4.1 Asia Lipid Nanoparticle Solutions Revenue by Application (2021-2026)
  8. 11.4.2 Asia Lipid Nanoparticle Solutions Revenue by Application (2027-2032)
  9. 11.5 Asia Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032)
  10. 11.6 Asia Lipid Nanoparticle Solutions Revenue by Country
  11. 11.6.1 Asia Lipid Nanoparticle Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Lipid Nanoparticle Solutions Revenue by Country (2021-2026)
  13. 11.6.3 Asia Lipid Nanoparticle Solutions Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lipid Nanoparticle Solutions Revenue (2021-2032)
  2. 12.2 SAMEA Lipid Nanoparticle Solutions Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Lipid Nanoparticle Solutions Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Lipid Nanoparticle Solutions Revenue by Type (2027-2032)
  5. 12.3 SAMEA Lipid Nanoparticle Solutions Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Lipid Nanoparticle Solutions Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Lipid Nanoparticle Solutions Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Lipid Nanoparticle Solutions Revenue by Application (2027-2032)
  9. 12.5 SAMEA Lipid Nanoparticle Solutions Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Lipid Nanoparticle Solutions Revenue by Country
  11. 12.6.1 SAMEA Lipid Nanoparticle Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Lipid Nanoparticle Solutions Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Lipid Nanoparticle Solutions Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst